← Back to Clinical Trials
Recruiting NCT05574634

NCT05574634 The Role of the Locus Coeruleus in Age-related Distractibility

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05574634
Status Recruiting
Phase
Sponsor Virginia Polytechnic Institute and State University
Condition Aging
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-04-11
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Tablet based adaptive multimodal attention practice programTablet based adaptive criterion task practice program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2023-04-11 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentional and cognitive processing. However, the underlying neurobiological pathophysiological changes in the brain that contribute to these declines are still largely unclear. The objective of this proposal is to investigate neural mechanisms of age-related attentional distractibility, focusing on the neural circuit initiated from the locus coeruleus (LC). In the current proposal, the investigators will test the hypothesis that the neural disconnectivity of LC with the salience network (SN) drives failures of ignoring distractors in older adults. The investigators will examine how LC-SN connectivity is associated with selective attention performance, and how improved LC-SN connectivity through a cognitive training program may lead to improved attentional performance.

Eligibility Criteria

Inclusion: * Healthy adult participants * No younger than 18 and no older than 75 yrs of age * Ability to provide written informed consent Exclusion: * History of surgery involving metal implants * Possible metal fragments in the eyes * Pacemaker * A history of claustrophobia * Braces * Weighing over 250 pounds * Pregnant or possibility of being pregnant. * Severe medical or psychiatric conditions (e.g., blind or deaf, head trauma) * Learning disabilities or developmental disabilities

Contact & Investigator

Central Contact

Tae-Ho Lee, PhD

✉ taehol@vt.edu

📞 540-231-6174

Principal Investigator

Tae-Ho Lee, PhD

PRINCIPAL INVESTIGATOR

Virginia Polytechnic Institute and State University

Frequently Asked Questions

Who can join the NCT05574634 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05574634 currently recruiting?

Yes, NCT05574634 is actively recruiting participants. Contact the research team at taehol@vt.edu for enrollment information.

Where is the NCT05574634 trial being conducted?

This trial is being conducted at Blacksburg, United States.

Who is sponsoring the NCT05574634 clinical trial?

NCT05574634 is sponsored by Virginia Polytechnic Institute and State University. The principal investigator is Tae-Ho Lee, PhD at Virginia Polytechnic Institute and State University. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology